This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Effectiveness results
The analysis found a significant increase in condom, (p=0.02) and contraceptive use, (p=0.03) at last intercourse among the 345 students who reported having sex in the last 3 months.
The Safer Choices programme appeared effective after 7 months (first follow-up assessment), since 52% of the students in the control group and 67% of those in the intervention group reported using condoms at last intercourse. In addition, 57% of the students in the control group and 68% of those in the intervention group used contraception at last intercourse.
Clinical conclusions
The effectiveness analysis showed that the Safer Choices programme was highly effective in increasing condom and contraceptive use among high-school students.
Modelling
A Bernoulli model of HIV transmission was used to translate the increase of condom used into cases of HIV and other STDs averted on the basis of four variables. The variables were the number of sexual partners, the number of sexual contacts with each partner, HIV prevalence, and probability of transmission. A pregnancy model was also constructed to translate contraceptive use into cases of pregnancy averted.
Outcomes assessed in the review
The outcomes assessed from published studies that were used as input parameters in the models were: the HIV prevalence rate or STD incidence rate of sexual partners; the probability of transmission following a single sex act; the effectiveness of condoms in preventing HIV and other STDs; the probability of condom use per act; the number of contacts with one partner within the last 3 months; the number of partners per student within the last 3 months; the probability that ovulation in a given month can support pregnancy; the probability of coitus in the fertile period; the probability of fertilisation given coitus in the fertile period;
the probability that a conception is recognised, given that fertilisation occurs;
the frequency of student sexual contacts within one month; and the percentage of students using contraception.
Study designs and other criteria for inclusion in the review
Not stated. However, some studies were official reports from bodies such as the US Preventive Services Task Force or Centres for Disease Control and Prevention.
Sources searched to identify primary studies
Not stated.
Criteria used to ensure the validity of primary studies
Not reported.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Six primary studies were the main source of the effectiveness evidence.
Methods of combining primary studies
Investigation of differences between primary studies
Results of the review
The prevalence rates of HIV, chlamydia, and gonorrhoea were 0.001, 0.117 and 0.009 in the age range 15 to 19 years. The rates were 0.004, 0.038 and 0.004 in the age range 10 to 44 years.
The probability of transmission following a single sex act was 0.016 (range: 0.001 -0.030) for HIV, 0.450 (range: 0.350 -0.550) for chlamydia, and 0.530 (range: 0.350 -0.700) for gonorrhoea.
The effectiveness of condoms in preventing HIV and other STDs was 0.95 for HIV, chlamydia and gonorrhoea.
For HIV, chlamydia and gonorrhoea, the probabilities of condom use per act were 0.52 in the control group and 0.67 (range: 0.64 -0.70) in the intervention group.
The number of contacts with one partner within the last 3 months was 3.63 in the intervention group. The number of partners per student within the last 3 months was 1.83.
The probability that ovulation in a given month can support pregnancy was 0.45.
The probability of coitus in the fertile period was 0.18.
The probability of fertilisation given coitus in the fertile period was 0.95.
The probability that a conception was recognised, given that fertilisation occurs, was 0.61.
The frequency of student sexual contacts within one month was 2.22 in the intervention group.
The proportion of students using contraception was 57% in the control group and 68% (range: 65 -71) in the intervention group.
Methods used to derive estimates of effectiveness
The authors made some assumptions to populate the model and to support the data derived from the literature and the single study. The authors also calculated some data.
Estimates of effectiveness and key assumptions
The authors assumed the following:
all sexual partners were of the opposite sex;
the sexual partners of intervention students were from a pool outside of the intervention group;
the intervention prevented both disease transmission from infected sexual partners to uninfected intervention students (primary transmission) and transmission from infected intervention students to uninfected sexual partners (secondary transmission); the HIV prevalence rates and STD incidence rates among sexual partners of intervention students were the average rates of two age groups, those aged 15 to 19 years and those aged 10 to 44 years; condom use per act was equal to the percentage of students using condoms at last intercourse; and the intervention effect lasted for one year.
The average prevalence rate was 0.002 (range: 0.001 -0.004) for HIV, 0.078 (range: 0.038 -0.117) for chlamydia, and 0.006 (range: 0.004 -0.009) for gonorrhoea.
The number of uninfected students in the intervention group was 343.70 for HIV, 185.17 for chlamydia, and 332.96 for gonorrhoea.
The number of uninfected sexual partners of infected students was 2.37 for HIV, 269.80 for chlamydia, and 21.90 for gonorrhoea.
The probability of becoming pregnant without contraceptive use was 0.05 within 1 month and 0.43 within one year.
The proportion of women who experienced a contraceptive failure within one year of initiating contraception was 9% (range: 5 -13).
The number of female students plus number of female partners of male intervention students was 488.18.
Measure of benefits used in the economic analysis
The benefit measures used in the economic analysis were the number of cases of HIV, chlamydia, gonorrhoea, pelvic inflammatory disease and pregnancy averted. All measures were obtained from the models.
